Literature DB >> 3124158

Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders.

D Healy1.   

Abstract

Current views on the organisation and functions of the circadian rhythm system are outlined. Evidence is presented supportive of the notion that the pathophysiology of the affective disorders involves a disruption of circadian rhythms and that the primary locus of action of agents effective in the affective disorders is on the circadian rhythm system. Potential disruptions of this system are enumerated. Such a hypothesis, it is argued, might potentially unite the disparate neurochemical and neuroendocrinological findings emerging in both depression and mania. There are in addition neuropsychological and nosological implications of such a framework, which may help bridge the divide between molecular and behavioural approaches to research on the affective disorders which are outlined.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124158     DOI: 10.1007/bf00187243

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  130 in total

1.  ECT versus chlorpromazine in mania.

Authors:  M S McCabe; B Norris
Journal:  Biol Psychiatry       Date:  1977-04       Impact factor: 13.382

Review 2.  Circadian rhythms and their mechanisms.

Authors:  D S Minors; J M Waterhouse
Journal:  Experientia       Date:  1986-01-15

3.  Effects of mood and severity on memory processes in depression and mania.

Authors:  M H Johnson; P A Magaro
Journal:  Psychol Bull       Date:  1987-01       Impact factor: 17.737

Review 4.  Cancer and the mind. Maudsley Bequest Lecture delivered before the Royal College of Psychiatrists, February 1983.

Authors:  S Greer
Journal:  Br J Psychiatry       Date:  1983-12       Impact factor: 9.319

5.  Dreaming: The functional state-shift hypothesis. A neuropsychophysiological model.

Authors:  M Koukkou; D Lehmann
Journal:  Br J Psychiatry       Date:  1983-03       Impact factor: 9.319

Review 6.  Clocked cell cycle clocks.

Authors:  L N Edmunds; K J Adams
Journal:  Science       Date:  1981-03-06       Impact factor: 47.728

7.  Lithium slows rat circadian activity rhythms.

Authors:  D F Kripke; V G Wyborney
Journal:  Life Sci       Date:  1980-04-21       Impact factor: 5.037

8.  Diurnal rhythm of alpha 2-noradrenergic receptors in the paraventricular nucleus and other brain areas: relation to circulating corticosterone and feeding behavior.

Authors:  M Jhanwar-Uniyal; C R Roland; S F Leibowitz
Journal:  Life Sci       Date:  1986-02-03       Impact factor: 5.037

9.  On the origin of early REM episodes in the sleep of depressed patients: a comparison of three hypotheses.

Authors:  H Schulz; R Lund
Journal:  Psychiatry Res       Date:  1985-09       Impact factor: 3.222

10.  A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression.

Authors:  B Claustrat; G Chazot; J Brun; D Jordan; G Sassolas
Journal:  Biol Psychiatry       Date:  1984-08       Impact factor: 13.382

View more
  12 in total

1.  Maintaining Daily Routines to Stabilize Mood: Theory, Data, and Potential Intervention for Circadian Consequences of COVID-19.

Authors:  Greg Murray; John Gottlieb; Holly A Swartz
Journal:  Can J Psychiatry       Date:  2020-09-10       Impact factor: 4.356

2.  Can the DRL 72s schedule selectively reveal antidepressant drug activity?

Authors:  A Jackson; W Koek; F C Colpaert
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

3.  Dysregulation of diurnal rhythms of serotonin 5-HT2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids.

Authors:  M C Holmes; K L French; J R Seckl
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

4.  Replicable differences in preferred circadian phase between bipolar disorder patients and control individuals.

Authors:  Joel Wood; Boris Birmaher; David Axelson; Mary Ehmann; Catherine Kalas; Kelly Monk; Scott Turkin; David J Kupfer; David Brent; Timothy H Monk; Vishwajit L Nimgainkar
Journal:  Psychiatry Res       Date:  2009-03-10       Impact factor: 3.222

Review 5.  Oscillatory serotonin function in depression.

Authors:  Ronald M Salomon; Ronald L Cowan
Journal:  Synapse       Date:  2013-05-21       Impact factor: 2.562

6.  Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder.

Authors:  Virginia Soria; Erika Martínez-Amorós; Geòrgia Escaramís; Joaquín Valero; Rosario Pérez-Egea; Cecilia García; Alfonso Gutiérrez-Zotes; Dolors Puigdemont; Mònica Bayés; José M Crespo; Lourdes Martorell; Elisabet Vilella; Antonio Labad; Julio Vallejo; Víctor Pérez; José M Menchón; Xavier Estivill; Mònica Gratacòs; Mikel Urretavizcaya
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

7.  Application of an ex vivo cellular model of circadian variation for bipolar disorder research: a proof of concept study.

Authors:  Mikhil N Bamne; Christine A Ponder; Joel A Wood; Hader Mansour; Ellen Frank; David J Kupfer; Michael W Young; Vishwajit L Nimgaonkar
Journal:  Bipolar Disord       Date:  2013-06-20       Impact factor: 6.744

Review 8.  Neuroleptics and psychic indifference: a review.

Authors:  D Healy
Journal:  J R Soc Med       Date:  1989-10       Impact factor: 18.000

Review 9.  Circadian rhythms and mood: opportunities for multi-level analyses in genomics and neuroscience: circadian rhythm dysregulation in mood disorders provides clues to the brain's organizing principles, and a touchstone for genomics and neuroscience.

Authors:  Jun Z Li
Journal:  Bioessays       Date:  2013-12-20       Impact factor: 4.345

Review 10.  Biological rhythms and mood disorders.

Authors:  Paola Salvatore; Premananda Indic; Greg Murray; Ross J Baldessarini
Journal:  Dialogues Clin Neurosci       Date:  2012-12       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.